Arnold M. Baskies
CIK: 0001683567
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Anixa Biosciences Inc
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 24, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $2.76$14K - Jul 27, 2026ANIX
Anixa Biosciences Inc
Exercise(M)Direct6K shares at avg. $3.13$19K - Jul 27, 2026ANIX
Anixa Biosciences Inc
Tax Payment(F)Direct5.4K shares at avg. $3.46$19K - Jan 28, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct10K shares at avg. $3.04$30K - Jan 5, 2026ANIX
Anixa Biosciences Inc
Award(A)DirectEmployee Stock Option
25K shares- - Jul 18, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.39$17K - Jan 28, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $2.82$14K - Jan 2, 2025ANIX
Anixa Biosciences Inc
Award(A)DirectEmployee Stock Option
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $2.76 | $13,800 | Direct |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | Exercise(M) | 6,000 | $3.13 | $18,780 | Direct |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | Tax Payment(F) | 5,428 | $3.46 | $18,781 | Direct |
| Jan 28, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 10,000 | $3.04 | $30,400 | Direct |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | Award(A) Employee Stock Option | 25,000 | - | - | Direct |
| Jul 18, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.39 | $16,950 | Direct |
| Jan 28, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $2.82 | $14,100 | Direct |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | Award(A) Employee Stock Option | 25,000 | - | - | Direct |
1-8 of 8 transactions
About Baskies Arnold M
Baskies Arnold M (SEC CIK 0001683567) files insider reports with the SEC as Director of Anixa Biosciences Inc (ANIX).
Signal8 holds 7 ownership filings by Baskies Arnold M, all Form 4s, filed between Jan 3, 2025 and Sep 28, 2026. Those filings report 8 transactions, from Jan 2, 2025 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Baskies Arnold M's filings is in SAN JOSE,, CA.
Recent filings by Baskies Arnold M
- Sep 24, 2026: Open-market purchase of ANIX shares (Form 4, code P).
- Jul 27, 2026: Option exercise of ANIX shares (Form 4, code M).
- Jul 27, 2026: Tax withholding of ANIX shares (Form 4, code F).
- Jan 28, 2026: Open-market purchase of ANIX shares (Form 4, code P).
- Jan 5, 2026: Grant or award of ANIX derivative securities (Form 4, code A).
Other insiders filing for Anixa Biosciences Inc (ANIX)
- KUMAR AMIT, Chief Executive Officer
- Titterton Lewis H jr, Director
- Gottschalk Emily, Director
- Catelani Michael, President, COO & CFO